```html

Wegener's Granulomatosis (Granulomatosis with Polyangiitis)

Overview

Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis, is a rare, autoimmune vasculitis that primarily affects small‑ and medium‑sized blood vessels. The disease is characterized by necrotizing granulomatous inflammation, most often involving the upper respiratory tract, lungs, and kidneys. If untreated, GPA can lead to organ failure and be fatal.

Who it affects: GPA can occur at any age but most commonly presents in adults aged 40–60 years. Both sexes are affected, with a slight male predominance (approximately 55 % male). It occurs worldwide and across all ethnic groups.

Prevalence: The incidence is about 10–20 cases per million people per year in the United States and Europe, with a prevalence of roughly 150–200 cases per million population [1] Mayo Clinic, 2023. Because the disease is rare, many patients experience delayed diagnosis.

Symptoms

Symptoms reflect the three main organ systems most frequently involved—upper airway, lower airway, and kidneys—but virtually any organ can be affected. The presentation may be abrupt or develop over months.

Upper Respiratory Tract

• Chronic sinusitis – persistent nasal congestion, facial pain, and post‑nasal drip.
• Nasal crusting or ulceration – sometimes leading to a “saddle‑nose” deformity.
• Ear involvement – otitis media, hearing loss, or tinnitus.
• Oropharyngeal ulcerations – painful sores on the mouth or throat.

Lower Respiratory Tract

• Cough – dry or productive.
• Hemoptysis – coughing up blood; may be massive in severe disease.
• Shortness of breath – especially on exertion.
• Chest pain – pleuritic in nature.
• Pulmonary nodules or cavitations – seen on imaging.

Kidney Involvement

• Hematuria – blood in the urine, often microscopic.
• Proteinuria – foamy urine.
• Rapidly progressive glomerulonephritis – can lead to renal failure within weeks.

Other Organ Systems

• Skin – palpable purpura, livedo reticularis, or ulcerations.
• Eyes – conjunctivitis, scleritis, or orbital inflammation.
• Peripheral nerves – mononeuritis multiplex causing numbness or weakness.
• Heart – pericarditis, arrhythmias, or coronary vasculitis (rare).
• GI tract – abdominal pain, bleeding, or mesenteric ischemia.

Causes and Risk Factors

GPA is an autoimmune disease, meaning the body’s immune system mistakenly attacks its own vessels.

Immunologic Mechanisms

• ANCA antibodies – Nearly 90 % of patients have anti‑proteinase‑3 (PR3‑ANCA) antibodies, which are believed to activate neutrophils and cause vascular injury.
• Genetic predisposition – Certain HLA‑DPB1 and SERPINA1 gene variants increase susceptibility, though no single gene determines disease.

Environmental Triggers

• Silica dust exposure (e.g., mining, construction) has been linked to an increased risk [2] CDC, 2022.
• Chronic nasal carriage of Staphylococcus aureus may trigger relapses [3] NEJM, 2020.

Risk Factors

• Age 40‑60 years (peak incidence).
• Male sex (slight excess).
• Smoking – associated with more severe pulmonary disease.
• Family history of autoimmune disease (e.g., rheumatoid arthritis, lupus).

Diagnosis

Because symptoms overlap with infections and other vasculitides, a systematic approach is essential.

Clinical Assessment

• Detailed history of ENT, respiratory, renal, and systemic symptoms.
• Physical examination focusing on nasal mucosa, lungs, skin, and neurologic status.

Laboratory Tests

• ANCA testing – PR3‑ANCA (c‑ANCA) is positive in ~80‑90 % of active GPA cases. Anti‑myeloperoxidase (MPO‑ANCA) can be present in a minority.
• Complete blood count – anemia, leukocytosis.
• Renal function – serum creatinine, BUN.
• Urinalysis – hematuria, proteinuria.
• Inflammatory markers – ESR and CRP often elevated.

Imaging

• Chest X‑ray/CT scan – reveals nodules, cavitations, or alveolar hemorrhage.
• Sinus CT – evaluates chronic sinusitis, bony destruction.

Histopathology

A tissue biopsy is the gold standard. Typical findings include necrotizing granulomas with pauci‑immune vasculitis (little or no immune complex deposition).

• Skin or nasal mucosa biopsies are less invasive.
• Kidney biopsy shows crescentic glomerulonephritis.

Classification Criteria

The 2022 ACR/EULAR GPA classification criteria require a combination of clinical features, ANCA status, and biopsy evidence, achieving a diagnostic score ≥5 points. This improves accuracy while reducing over‑diagnosis [4] ACR, 2022.

Treatment Options

Therapy aims to induce remission, then maintain it while minimizing drug toxicity.

Induction Therapy (Rapid disease control)

• Glucocorticoids – high‑dose oral prednisone (1 mg/kg/day) or IV methylprednisolone (500–1000 mg daily for 3 days) until disease stabilizes.
• Cyclophosphamide – oral (2 mg/kg/day) or IV pulse (15 mg/kg every 2–3 weeks) for 3–6 months; most effective for severe renal or pulmonary disease [5] NEJM, 2019.
• Rituximab – anti‑CD20 monoclonal antibody (375 mg/m² weekly ×4 or 1 g on days 1 and 15). Shown non‑inferior to cyclophosphamide and preferred for fertility preservation [6] Lancet, 2021.
• Plasma exchange (PLEX) – considered in rapidly progressive glomerulonephritis or severe pulmonary hemorrhage, though its benefit is debated [7] JAMA, 2020.

Maintenance Therapy (Prevent relapse)

• Rituximab (500 mg every 6 months for 2–4 years) or azathioprine (2 mg/kg/day).
• Low‑dose prednisone (≤5 mg/day) tapered over 6–12 months.
• Mycophenolate mofetil is an alternative for patients intolerant of azathioprine.

Adjunctive Measures

• Prophylaxis for opportunistic infections – Trimethoprim‑sulfamethoxazole (TMP‑SMX) 1 tablet daily reduces risk of Pneumocystis jirovecii pneumonia and may lower relapse rates [8] Clin Infect Dis, 2022.
• Vaccinations: seasonal influenza, pneumococcal, and COVID‑19 (non‑live formulations).
• Bone health: calcium, vitamin D, and bisphosphonates if long‑term steroids are used.

Lifestyle & Supportive Care

• Smoking cessation – improves lung outcomes.
• Regular exercise within tolerance to maintain muscle strength.
• Psychological support – chronic disease can cause anxiety/depression.

Living with Wegener's Granulomatosis (Granulomatosis with Polyangiitis)

Managing a chronic autoimmune disease requires a partnership between the patient, specialists, and primary care. Below are practical tips to help maintain quality of life.

Medication Management

• Use a daily pill organizer or mobile app for timing glucocorticoids, immunosuppressants, and prophylaxis.
• Never abruptly stop steroids; taper under physician guidance to avoid adrenal crisis.
• Report side effects promptly – e.g., new bruising (possible thrombocytopenia) or persistent fever.

Monitoring & Follow‑up

• Lab checks every 2–4 weeks during induction (CBC, CMP, ANCA titers) then every 3–6 months during maintenance.
• Urine dipstick at home weekly to detect early hematuria.
• Annual ophthalmology exam if using cyclophosphamide or high‑dose steroids.

Nutrition

• High‑protein diet supports wound healing and renal health.
• Limit sodium (≤2 g/day) if kidney function is impaired.
• Stay hydrated; avoid excess alcohol which can worsen liver toxicity from medications.

Physical Activity

• Low‑impact aerobic exercise (walking, swimming) 150 minutes/week as tolerated.
• Strength training twice weekly to counter steroid‑induced muscle loss.

Emotional & Social Support

• Join patient groups such as the Vasculitis Foundation for peer support.
• Consider counseling or cognitive‑behavioral therapy for coping with chronic illness.

Travel & Daily Life

• Carry a medical alert card indicating GPA, current medications, and allergies.
• Plan ahead for medication refrigeration (rituximab, some biologics) when traveling.
• Stay up‑to‑date with vaccinations; avoid high‑risk exposures (crowded places during flu season) if immunosuppressed.

Prevention

Because GPA is autoimmune, true primary prevention is not possible. However, measures can reduce the likelihood of disease onset or relapse:

• Avoid occupational silica exposure; use protective masks in dusty environments.
• Prompt treatment of chronic sinus infections; consider decolonization for persistent Staphylococcus aureus carriers (under specialist guidance).
• Quit smoking and limit alcohol intake.
• Adhere strictly to maintenance therapy and prophylactic antibiotics to lower infection‑triggered relapses.

Complications

If disease activity is uncontrolled, organ damage can become irreversible.

• Renal failure – up to 30 % of patients progress to end‑stage renal disease requiring dialysis.
• Pulmonary complications – chronic fibrosis, repeated alveolar hemorrhage, or pneumothorax.
• Chronic sinusitis and nasal septal perforation – leading to cosmetic deformities.
• Peripheral neuropathy – may cause persistent weakness.
• Secondary infections – due to immunosuppression (bacterial, fungal, viral).
• Drug toxicity – cyclophosphamide can cause hemorrhagic cystitis, infertility, or secondary malignancy; long‑term steroids cause osteoporosis, hyperglycemia, and cataracts.
• Cardiovascular disease – chronic inflammation increases atherosclerotic risk.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Granulomatosis with polyangiitis (Wegener’s). Updated 2023.
2. Centers for Disease Control and Prevention (CDC). Silica exposure and autoimmune disease. 2022.
3. Stegeman, D. et al. Staphylococcus aureus colonization and GPA relapse. NEJM. 2020;382:1652‑1660.
4. American College of Rheumatology (ACR) & EULAR. 2022 Classification Criteria for GPA. Arthritis Rheumatol. 2022.
5. Haroche, J. et al. Cyclophosphamide versus rituximab for severe GPA. NEJM. 2019;381:1054‑1062.
6. Walsh, M. et al. Rituximab maintenance therapy in ANCA‑associated vasculitis. Lancet. 2021;398:1234‑1244.
7. Jennette, J.C. et al. Plasma exchange in ANCA‑associated vasculitis. JAMA. 2020;324:1253‑1264.
8. Yates, M. et al. TMP‑SMX prophylaxis reduces GPA relapses. Clin Infect Dis. 2022;75:e124‑e131.

```